Macular Society welcomes GMC decision to strike off high profile eye surgeon

20 September 2019
Source: The Macular Society

Leading eye charity the Macular Society has welcomed a decision to strike off high profile Harley Street ophthalmologist Bobby Qureshi for lying to patients about being able to restore their sight. Following a hearing by the Medical Practitioners’ Tribunal Service which ended this week, Mr Qureshi was banned by the General Medical Council (GMC) from practising as a doctor for

Read more Macular Society welcomes GMC decision to strike off high profile eye surgeon

ABDO: Macular Society: Nearly 1.5m people in the UK affected by biggest cause of blindness

9 November 2018
Source: ABDO

New figures have revealed that nearly 1.5m people in the UK are affected by macular disease, the nation’s biggest cause of blindness. The statistics revealed by national sight loss charity, the Macular Society, have been released on World Sight Day to highlight the extent of what is now an urgent public health issue. Macular disease is a progressive disease, which

Read more ABDO: Macular Society: Nearly 1.5m people in the UK affected by biggest cause of blindness

BBC News: NHS to save ‘hundreds of millions’ in landmark (Avsatin) drug ruling

21 September 2018
Source: BBC News

A landmark ruling against two leading drug companies could save the NHS “hundreds of millions” a year. Novartis and Bayer were trying to stop NHS doctors from prescribing a cheaper treatment for a serious eye condition. Twelve NHS bodies in the north east of England were offering patients Avastin, a cheaper alternative to the licensed drug, Lucentis. Health bosses said

Read more BBC News: NHS to save ‘hundreds of millions’ in landmark (Avsatin) drug ruling

Macular Society: Treatment trial for Stargardt diseases reaches the UK

12 February 2018
Source: Macular Society

Researchers in the south of England will become the first in the UK to trial a new drug that could prevent sight loss caused by Stargardt disease, a currently untreatable condition. Stargardt disease, also known as Stargardt macular dystrophy, affects the area of the retina called the macula and causes a reduction in central vision. It is the most common form of juvenile macular

Read more Macular Society: Treatment trial for Stargardt diseases reaches the UK

NICE: Draft guideline on Macular degeneration

13 July 2017
Source: NICE

This draft guideline and its supporting evidence are now out for consultation. VISION 2020 UK is looking to submit comments on the draft guideline; it is a valuable opportunity to ensure that the guideline considers issues important to our members please do send any comments to m.broom@VISION2020UK.org.uk. The consultation page has all the information and documents.  We would very much appreciate

Read more NICE: Draft guideline on Macular degeneration

Macular Society’s call for more funding of research into macular degeneration secures leading expert endorsement

28 June 2016
Source: Macular Society

Charity’s landmark report exposing lack of investment in age-related macular degeneration (AMD) is supported by more than 60 of the UK’s foremost sight researchers, ophthalmologists and institutions Situation described as ‘urgent’  It is a disease with devastating and far-reaching consequences for both patients and their families, and the number of diagnoses is on the rise. But age-related macular degeneration (AMD)

Read more Macular Society’s call for more funding of research into macular degeneration secures leading expert endorsement

Guardian: Cheap blindness drug should be made widely available, says WHO

1 June 2016
Source: Guardian

World Health Organisation rejects expensive licensed drug Lucentis to be added to list for all countries in favour of much cheaper Avastin, not yet available in UK. All countries should make available a cheap, unlicensed drug to prevent blindness in older people – one in preference to the expensive licensed version promoted by pharmaceutical companies, a World Health Organisation committee

Read more Guardian: Cheap blindness drug should be made widely available, says WHO

Macular Society: Research trials – participant sign up

6 April 2016
Source: Macular Society

There are many clinical trials and research studies looking at new treatments and ultimately   trying to find a cure for macular disease. The Macular Society are often approached to help find people to participate in clinical trials and research studies. Involvement can range from providing feedback on new developments, to undergoing treatment as part of a trial. The Macular

Read more Macular Society: Research trials – participant sign up